MDT

98.5

+2.11%↑

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

Inicio・Lista de Acciones・Pulse Biosciences Inc

Pulse Biosciences Inc

Cerrado

SectorSanidad

14.31 1.85

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

14.05

Máximo

14.33

Métricas clave
By Trading Economics
Ingresos	-217K -19M
Ventas	86K 86K
BPA	-0.29
Margen de beneficios	-22,540.698
Empleados	75
EBITDA	-228K -19M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+51% upside

Dividendos
By Dow Jones
Próximas Ganancias	26 mar 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-179M 958M
Apertura anterior	12.46
Cierre anterior	14.31

Noticias sobre sentimiento de mercado

By Acuity

38%

62%

106 / 361 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

16.59 / 17.17 Soporte y Resistencia

Pulse Biosciences Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

14 ene 2026, 22:41 UTC

Adquisiciones, fusiones, absorciones

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

15 ene 2026, 00:00 UTC

Ganancias

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

14 ene 2026, 23:47 UTC

Charlas de Mercado

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

14 ene 2026, 23:44 UTC

Charlas de Mercado

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

14 ene 2026, 23:39 UTC

Charlas de Mercado

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

14 ene 2026, 23:32 UTC

Charlas de Mercado

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

14 ene 2026, 22:56 UTC

Adquisiciones, fusiones, absorciones

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

14 ene 2026, 22:53 UTC

Adquisiciones, fusiones, absorciones

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

14 ene 2026, 22:17 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

14 ene 2026, 22:17 UTC

Charlas de Mercado

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

14 ene 2026, 22:09 UTC

Ganancias

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

14 ene 2026, 22:08 UTC

Ganancias

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

14 ene 2026, 22:08 UTC

Ganancias

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

14 ene 2026, 21:53 UTC

Adquisiciones, fusiones, absorciones

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

14 ene 2026, 21:53 UTC

Adquisiciones, fusiones, absorciones

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

14 ene 2026, 21:52 UTC

Adquisiciones, fusiones, absorciones

WuXi XDC Announces Positive Profit Alert for 2025

14 ene 2026, 21:51 UTC

Adquisiciones, fusiones, absorciones

Citigroup Acting as Financial Advisor to WuXi XDC

14 ene 2026, 21:51 UTC

Adquisiciones, fusiones, absorciones

WuXi XDC: Aims to Keep Listing Status of BioDlink

14 ene 2026, 21:51 UTC

Adquisiciones, fusiones, absorciones

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

14 ene 2026, 21:50 UTC

Charlas de Mercado

Ganancias

Financial Services Roundup: Market Talk

14 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

14 ene 2026, 21:49 UTC

Adquisiciones, fusiones, absorciones

WuXi XDC: BioDlink Offer to Cost HK$2.79B

14 ene 2026, 21:48 UTC

Adquisiciones, fusiones, absorciones

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

14 ene 2026, 21:48 UTC

Adquisiciones, fusiones, absorciones

WuXi XDC Makes Cash Offer for BioDlink International

14 ene 2026, 21:13 UTC

Charlas de Mercado

Oil Retreats Late After Trump Comments on Iran -- Market Talk

14 ene 2026, 20:30 UTC

Charlas de Mercado

Ganancias

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

14 ene 2026, 20:13 UTC

Charlas de Mercado

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

14 ene 2026, 20:08 UTC

Charlas de Mercado

Oil Futures Extend Rally on Iran Tensions -- Market Talk

14 ene 2026, 19:33 UTC

Charlas de Mercado

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

14 ene 2026, 19:06 UTC

Charlas de Mercado

Ganancias

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Comparación entre iguales

Cambio de precio

Pulse Biosciences Inc previsión

Precio Objetivo

By TipRanks

51% repunte

Estimación a 12 Meses

Media 22 USD 51%

Máximo 22 USD

Mínimo 22 USD

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pulse Biosciences Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

1 ratings

Comprar

Mantener

Vender

De acuerdo con 1 analistas que ofrecen calificaciones bursátiles a para Pulse Biosciences Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

16.59 / 17.17Soporte y Resistencia

Recent bearish events outweigh bullish events.

Sentimiento

By Acuity

106 / 361 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.